153 related articles for article (PubMed ID: 33304244)
1. The Possible Role of MOPr-DOPr Heteromers and Its Regulatory Protein RTP4 at Sensory Neurons in Relation to Pain Perception.
Fujita W
Front Cell Neurosci; 2020; 14():609362. PubMed ID: 33304244
[TBL] [Abstract][Full Text] [Related]
2. [MOPr-DOPr heteromer: the meaning and possibility as novel therapeutic target for pain control].
Fujita W
Nihon Yakurigaku Zasshi; 2021; 156(3):134-138. PubMed ID: 33952839
[TBL] [Abstract][Full Text] [Related]
3. Aiming at Ideal Therapeutics-MOPr/DOPr or MOPr-DOPr Heteromertargeting Ligand.
Fujita W
Curr Top Med Chem; 2020; 20(31):2843-2851. PubMed ID: 32324516
[TBL] [Abstract][Full Text] [Related]
4. Receptor Transporter Protein 4 (RTP4) in the Hypothalamus Is Involved in the Development of Antinociceptive Tolerance to Morphine.
Fujita W; Uchida H; Kawanishi M; Kuroiwa Y; Abe M; Sakimura K
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291680
[TBL] [Abstract][Full Text] [Related]
5. Regulation of an Opioid Receptor Chaperone Protein, RTP4, by Morphine.
Fujita W; Yokote M; Gomes I; Gupta A; Ueda H; Devi LA
Mol Pharmacol; 2019 Jan; 95(1):11-19. PubMed ID: 30348895
[TBL] [Abstract][Full Text] [Related]
6. The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling.
Fidilio A; Grasso M; Turnaturi R; Caruso G; Spitale FM; Vicario N; Parenti R; Spoto S; Musso N; Marrazzo A; Chiechio S; Caraci F; Pasquinucci L; Parenti C
Front Pharmacol; 2021; 12():749365. PubMed ID: 34690781
[TBL] [Abstract][Full Text] [Related]
7. Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.
Hack SP; Bagley EE; Chieng BC; Christie MJ
J Neurosci; 2005 Mar; 25(12):3192-8. PubMed ID: 15788776
[TBL] [Abstract][Full Text] [Related]
8. Spinal μ and δ opioids inhibit both thermal and mechanical pain in rats.
Normandin A; Luccarini P; Molat JL; Gendron L; Dallel R
J Neurosci; 2013 Jul; 33(28):11703-14. PubMed ID: 23843537
[TBL] [Abstract][Full Text] [Related]
9. The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice.
Hervera A; Negrete R; Leánez S; Martín-Campos J; Pol O
J Pharmacol Exp Ther; 2010 Sep; 334(3):887-96. PubMed ID: 20498253
[TBL] [Abstract][Full Text] [Related]
10. Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy.
Olson KM; Devereaux AL; Chatterjee P; Saldaña-Shumaker SL; Shafer A; Plotkin A; Kandasamy R; MacKerell AD; Traynor JR; Cunningham CW
Front Pharmacol; 2023; 14():1230053. PubMed ID: 37469877
[No Abstract] [Full Text] [Related]
11. Delta opioid receptor-mediated analgesia is not altered in preprotachykinin A knockout mice.
Dubois D; Gendron L
Eur J Neurosci; 2010 Dec; 32(11):1921-9. PubMed ID: 21044181
[TBL] [Abstract][Full Text] [Related]
12. Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain.
Jimenez-Vargas NN; Gong J; Wisdom MJ; Jensen DD; Latorre R; Hegron A; Teng S; DiCello JJ; Rajasekhar P; Veldhuis NA; Carbone SE; Yu Y; Lopez-Lopez C; Jaramillo-Polanco J; Canals M; Reed DE; Lomax AE; Schmidt BL; Leong KW; Vanner SJ; Halls ML; Bunnett NW; Poole DP
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15281-15292. PubMed ID: 32546520
[TBL] [Abstract][Full Text] [Related]
13. Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.
Décaillot FM; Rozenfeld R; Gupta A; Devi LA
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):16045-50. PubMed ID: 18836069
[TBL] [Abstract][Full Text] [Related]
14. Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain?
Cairns BE; Arendt-Nielsen L; Sacerdote P
Scand J Pain; 2015 Jan; 6(1):3-6. PubMed ID: 29911589
[TBL] [Abstract][Full Text] [Related]
15. The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential.
Burtscher J; Schwarzer C
Front Mol Neurosci; 2017; 10():245. PubMed ID: 28824375
[TBL] [Abstract][Full Text] [Related]
16. In vivo trafficking of endogenous opioid receptors.
Wang Y; Van Bockstaele EJ; Liu-Chen LY
Life Sci; 2008 Nov; 83(21-22):693-9. PubMed ID: 18930741
[TBL] [Abstract][Full Text] [Related]
17. Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.
Reyes BAS; Kravets JL; Connelly KL; Unterwald EM; Van Bockstaele EJ
Brain Struct Funct; 2017 Mar; 222(2):1007-1026. PubMed ID: 27376372
[TBL] [Abstract][Full Text] [Related]
18. Membrane glycoprotein M6A promotes mu-opioid receptor endocytosis and facilitates receptor sorting into the recycling pathway.
Liang YJ; Wu DF; Stumm R; Höllt V; Koch T
Cell Res; 2008 Jul; 18(7):768-79. PubMed ID: 18574501
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception.
Schepers RJ; Mahoney JL; Shippenberg TS
Pain; 2008 Jun; 136(3):320-330. PubMed ID: 17764840
[TBL] [Abstract][Full Text] [Related]
20. Delta opioid receptor expression correlates to skin ageing and melanin expression in Asian women.
Bigliardi PL; Lo S; Bigliardi E; Dancik Y; Leblanc-Noblesse E; Bigliardi-Qi M
Exp Dermatol; 2024 Jun; 33(6):e15096. PubMed ID: 38922774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
